ALEMBIC PHARMACEUTICALS LTD.

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.

Comment

Name	Companies Held
Hitesh Ramji Javeri	50
Mahendra Girdharilal	50
Sangeetha S	50
Dheeraj Kumar Lohia	42
Mukul Agrawal	39

Name	Companies Held
Hdfc Trustee Company Limited	100
Reliance Capital Trustee C...	87
Birla Sun Life Trustee Com...	62
President Of India	54
General Insurance Corporat...	51

Name	Returns(%)
Name	Week	Month	Year
Quant Active Fund - Reg - G	0.22%	7.89%	47.82%
UTI - Equity Fund. - Reg - G	-2.40%	5.51%	30.78%
ICICI Prudential Focused Equity Fund - Reg - G	-0.34%	7.52%	28.67%
Quant Focused Fund - Reg - G	-1.12%	7.49%	26.69%
Canara Robeco Bluechip Equity Fund - Reg - G	-1.01%	5.13%	23.74%

Name	Returns(%)
Name	Week	Month	Year
DHFL Pramerica Midcap Opportunities Fund - Reg - G	-1.38%	8.08%	47.58%
Kotak Small Cap Fund - Reg - G	-1.23%	6.48%	31.51%
SBI SMALL CAP FUND - Reg - G	-1.68%	5.11%	30.87%
UTI - Mid Cap Fund - Reg - G	-1.70%	5.79%	30.26%
SBI MAGNUM MIDCAP FUND - Reg - G	-1.41%	5.97%	29.68%

Name	Returns(%)
Name	Week	Month	Year
Quant Mid Cap Fund - Reg - G	-0.84%	5.70%	42.23%
DHFL Pramerica Diversified Equity Fund - Reg - G	-1.36%	6.40%	34.96%
Quant Large & Mid Cap Fund - Reg - G	-1.66%	5.32%	31.35%
Franklin India Opportunities Fund - Reg - G	-1.70%	7.78%	31.13%
Parag Parikh Long Term Equity Fund - Reg - G	-0.25%	3.11%	30.34%

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Now Trending